Device warning letters issued by FDA drop 36% to 417 in FY 1996.
This article was originally published in The Gray Sheet
Executive SummaryFDA DEVICE WARNING LETTERS FALL BY 36% IN FY 1996, reversing a steady upward trend in the number of letters issued by the agency since 1990. The 417 device warning letters issued by FDA's field offices and the Center for Devices and Radiological Health in fiscal 1996 are the fewest since 1991, when the agency sent out about 200 letters.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.